글로벌 비경구 영양 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

신체는 비경구 영양 공급으로부터 설탕, 탄수화물, 단백질, 지방, 전해질, 미량 원소를 포함한 영양소를 받습니다. 이러한 영양소는 높은 수준의 힘, 수분, 에너지를 유지하는 데 필수적입니다.

Data Bridge Market Research는 2021년에 63억 달러였던 비경구 영양 시장이 2029년까지 93억 8천만 달러로 급증할 것으로 분석했으며, 2022년부터 2029년까지의 예측 기간 동안 5.10%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

시장 정의

In both developing and established economies, malnourishment is a major contributor to inflammatory bowel disease (IBD), which affects a significant portion of the population. On a larger scale, total parenteral nutrition (TPN) serves as a major treatment for IBD by addressing the nutritional shortage brought by the conclusion of intestinal failure.

Parenteral Nutrition Market Dynamics

Drivers

• Rising metabolic disorders

One of the key factors driving the expansion of the parenteral nutrition market in the present is the rise in metabolic disorders along with chronic diseases like diabetes. The parenteral nutrition industry will expand as a result of the rising rate of malnutrition in the world. Additionally, one of the main factors driving the expansion of the parenteral nutrition market is the ageing population, which is increasing.

• Increasing chronic diseases

Rapid modernization, poor dietary intake of a balanced diet, and the rising frequency of chronic diseases all contribute to the need for the parenteral nutrition industry.

• Increasing prevalence of malnutrition

The need for parenteral nutrition has increased as a result of the rising incidence of malnutrition around the world. This demand is anticipated to favourably influence the industry's development. Additionally, there was a strong demand for intravenous feeding as a result of the supportive government initiatives to lessen the impact of malnutrition.

Opportunities

The rise in childhood malnutrition, particularly in developing and emerging economies worldwide, is anticipated to fuel the growth of the parenteral nutrition market. Additionally, the parenteral nutrition industry would have promising growth prospects due to the need for parenteral nutrition to properly balance amino acids, lipids, vitamins, minerals, and other nutrients.

 Restraints/Challenges

Despite this, the acceptability of parenteral feeding products is subject to stringent government regulations, particularly in emerging economies, which will restrain the market's expansion. One of the main obstacles to the growth of the parenteral nutrition industry in the anticipated term is the lack of information among people in developed nations.

This parenteral nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the parenteral nutrition market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Parenteral Nutrition Market

The parenteral nutrition market value has been impacted by the extraordinary global health issue caused by the COVID-19 virus outbreak. Parenteral nutrition played a crucial part in the treatment of malnutrition caused by the COVID-19 infection in patients all over the world. A severe lack of appetite brought on by the COVID-19 infection was accompanied by other symptoms that worsened immune defences and caused muscle mass loss. In response to this illness, hospitals and clinics have increased the number of healthcare facilities available for patients who need diet tailored to their sickness. Such advancements are likely to increase patient demand for and adoption of intravenous nutrition administration.

Recent Development

• In July 2021, Micrel Medical, a manufacturer of medical devices with a focus on infusion therapy, and Baxter Healthcare (Baxter) inked a contract. In accordance with this agreement, the businesses would market the infusion pump Micrel Mini Rythmic PN+ for parenteral nutrition (PN).
• Sep 2020: The U.S. Food and Drug Administration (FDA) gave its approval to Baxter International's new Clinimix Injections and Clinimix E Injections formulations. It is easier to reach patient protein targets with the new Clinimix formulations because they contain up to 80 g/L of amino acids, the highest amount of protein in any multi-chamber bag currently available in the United States also contain less fluid and dextrose than previous formulations.

 Global Parenteral Nutrition Market Scope

The parenteral nutrition market is segmented on the basis of nutrition type, consumer type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Nutrient Type

• Carbohydrates
• Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins and Minerals

Consumer Type

• Children and New-born
• Adults

End-User

• Clinic
• Hospital
• Others

Parenteral Nutrition Market Regional Analysis/Insights

The parenteral nutrition market is analysed and market size insights and trends are provided by country, nutrition type, consumer type, and end-user as referenced above.

The countries covered in the parenteral nutrition market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

북미는 정부 기관과 민간 기업이 의료 분야에서 막대한 연구 비용을 투자하는 중요성으로 인해 비경구 영양제 시장을 장악하고 있습니다.

아시아 태평양 지역은 신흥국의 경제 발전과 의료 인프라 및 환불 관행을 개선하기 위한 적절한 정부 이니셔티브의 결과로 예측 기간 동안 증가할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 비경구 영양제 시장 점유율 분석

비경구 영양제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 비경구 영양제 시장과 관련된 회사의 초점에만 관련이 있습니다.

비경구 영양제 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 백스터(미국)
• 오츠카제약공장 주식회사(도쿄)
• 포브스 미디어 LLC(미국)
• Kelun.com(중국)
• Vifor Pharma Management Ltd. (스위스)
• AbbVie Inc.(미국)
• B.Braun Melsungen AG(독일)
• Fresenius SE & Co. KGaA(독일)
• 그리폴스 SA(스페인)
• 파이저 주식회사(미국)
• ICU Medical, Inc. (미국)
• 안휘메디팜(중국)
• aculife(인도)
• Servona GmbH(독일)

SKU-34734